Immunological Agents

123456789101112131415161718192021222324252627282930
Across
  1. 4. Cytomegalovirus, herpes simplex, herpes zoster.
  2. 5. Type of immunity when antigen enters the body w/o human assistance.
  3. 8. New copies of HIV can now infect other cells.
  4. 11. Immunity that every person's body make.
  5. 12. Common side effect of raltegavir.
  6. 16. The most effective and long lasting type of immunity
  7. 17. Life cycle wherein RNA polymerase creates a copies of HIV genomic material.
  8. 18. A blueprint to amke long chains of HIV proteins.
  9. 19. Inhibiting the activity of protease.
  10. 20. Related to opportunistic pathogens experienced by low percentage of patients in ART.
  11. 21. All NRTIs except _ should be taken with food.
  12. 23. Cell that the HIV destroys.
  13. 26. Necessary for the virus to bind to CD4
  14. 27. The standard tretment with HIV infection.
  15. 28. Prevent viral replication by competing with binding of the reverse transcriptase enzyme.
  16. 29. Type of infection wherein patients are more vulnerable to infections and malignancies
  17. 30. Drug associated with potentially life-threatening and fatal skin reactions.
Down
  1. 1. Drugs hat limits the ability of virus to replicate and infect new cell.
  2. 2. HIV enzymes that cuts long chain of HIV proteins.
  3. 3. Vaccinations to tetanus, measles, smallpox etc.
  4. 6. New virus is assembled
  5. 7. HIV enzyme that hides the HIV DNA within the host cell.
  6. 9. The newly assembled virus pushes out "buds" from the host cell.
  7. 10. Short-term protection against a specific antigen.
  8. 13. Tuberculosis, bacterial pneumonia, septicemia.
  9. 14. Wasting of fat.
  10. 15. Only agent approved in Entry Inhibitor.
  11. 21. First-choiceof drug in Protein Inhibitor
  12. 22. First-choice drug within the NNRTI class.
  13. 24. Acts by interfereing with HIV viral RNA-dependent DNA polymerase.
  14. 25. Alternative drug in adult patients during pregnancy.